Guidance: Clinical Pharmacology Considerations for Antibody-Drug Conjugates

TitleGuidance: Clinical Pharmacology Considerations for Antibody-Drug Conjugates
ToC Doc Clinical Pharmacology Considerations for Antibody-Drug Conjugates
Docket Number2022-02604
Type Notice
Subject Guidance:
Clinical Pharmacology Considerations for Antibody-Drug Conjugates
Publication Date2022-02-08
Last Updated Date 2022-02-07 08:15:08 -0500
Last Public Inspection2022-02-07
Filed At2022-02-07T08:45:00.000-05:00
PDF 2022-02604_PI.pdf (105974 bytes)
Download TXT / HTML / JSON
Number of Pages 6
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021